Synthetic Biologics Inc (SYN): Synthetic Biologics: Randal Kirk And A Robust Pipeline For 2014 - Seeking Alpha

Synthetic Biologics Inc (SYN): Synthetic Biologics: Randal Kirk And A Robust Pipeline For 2014 - Seeking Alpha

Here is a great article on SYN, a biotech company involved with developing anti-infection drugs.  I bought shares in the company this morning, and it is one of the few biotech stocks that I own.  As most people know, use of antibiotic drugs can be overdone, and thousands of people die each year from a side-effect of antibiotics.  This is where SYN comes in.  They have a drug that defeats the c. diff infection that mass antibiotics introduces.  The drug will most likely get a fast track status.  SYN also has other worthwhile drugs in their pipeline as well. So, I think the company is worth owning at $1.50 per share.  One securities company has a $4 price target on SYN, and it could go higher than that if their drugs are approved.